about
Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South SpainClinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendationsUse of deep sequencing data for routine analysis of HIV resistance in newly diagnosed patients.Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains.Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure.The cobas® HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice.Improving Clinical Laboratory Efficiency: Introduction of Systems for the Diagnosis and Monitoring of HIV Infection.Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition.Minimizing Next-Generation Sequencing Errors for HIV Drug Resistance Testing.Obesity and Asthma: A Missing Link.Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools.Resistance testing for the treatment of chronic hepatitis C with direct acting antivirals: when and for how long?Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults.Protease inhibitor monotherapy is not associated with increased viral replication in lymph nodes.Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing.Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach.The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice.Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysisMicroenvironment Eradication of Hepatitis C: A Novel Treatment ParadigmProceedings of The 8th Romanian National HIV/AIDS Congress and The 3rd Central European HIV Forum : Sibiu, Romania. 5-7 May 2016Diagnóstico de laboratorio de la infección por el VIH, del tropismo viral y de las resistencias a los antirretroviralesPredicting antiretroviral drug resistance from the latest or the cumulative genotypeLa respuesta virológica al tratamiento con adefovir dipivoxil predice el desarrollo de resistencias a largo plazo en pacientes con hepatitis crónica B HBeAg negativo previamente no tratadosResistencias genotípicas en pacientes con VIH-1 y grados de viremia persistentemente bajosTransmitted Resistance in Newly Diagnosed HIV-Infected Individuals in South Eastern Spain (2005–2007). Detection of Minority Viral Quasispecies[490] GENOTYPE A2 INFLUENCE UPON THE RESPONSE TO ADEFOVIR DIPIVOXIL TREATMENTVirological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but PossiblePhaeohyphomycosis due to Pleurostomophora richardsiae: an uncommon cutaneous fungal infection.Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in SpainAutism Spectrum Disorder (ASD) with and without Mental Regression is Associated with Changes in the Fecal MicrobiotaAssociation of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical studyImmunomodulatory tetracyclines ameliorate DNBS-colitis: Impact on microRNA expression and microbiota compositionImmunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolutionIntestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota compositionSurveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice
P50
Q28354115-1FC2C83E-196A-4A9E-BAF5-685BF305300FQ28540964-FF5D1B9D-A9C9-4DF8-B4E0-A48AB10BEC50Q30869829-9B342176-5779-4623-824F-B760910B01DFQ35643130-60116433-3C6F-4E22-B72C-EEE1E94C6352Q35994877-CF98C0CC-706F-444E-84A0-AFA12980B1D9Q36017591-E108567A-A742-465E-A72B-2446C2D9166FQ36347235-39148BDB-D19B-4C99-A279-4C625FA90FC6Q36481637-9347FBA2-E10A-4B45-81D0-73C172861E64Q36497842-40574E5A-CD46-4BAE-B2D9-22744BD8EB9DQ36543845-7F3F0CFC-B814-4724-A659-809DDDEE4D47Q38650504-581A8028-05C2-4D2A-ABDE-4DE7F6B54D88Q38769148-4851C828-15E4-4127-A53A-E9C82204FC57Q39428297-B62E0737-6791-4EBE-BD39-949AE717B319Q39868522-B223E5E2-456E-4F95-86DE-18E91A47FEE4Q40282635-2EE6DCF0-CF84-4175-85AE-9891B755FD1AQ41512678-F99F5E04-ECE9-4986-BDFE-293619E047B1Q42214987-FF9DC763-2FEF-4880-A96E-F991D4AD0B79Q42215713-8D4769C7-15A1-43DA-8A45-D8EB7B2CD097Q42226571-68684FBD-7517-43E7-8A50-6C503926CA5EQ46100244-3857CB32-8CCB-4866-9546-8FB3D80A71ADQ46209757-939484E4-8D03-42B5-B70D-00AED1B0A770Q55019416-AD510247-88AF-4D61-9A94-AF6EC6D73B3AQ56782091-0D1D37E3-E9FF-4C80-AC68-4C4347BE5661Q59358097-C433A4A7-A727-4E60-A8FE-DDEA7365A03AQ59404052-773F5644-13A3-40CD-A708-0657EB4B580FQ59404105-3F2DF0D3-F5D3-4DDA-83B5-7534E18DFDE7Q59404111-1E3203D8-AC46-4207-9563-A852DB20BBF7Q59404120-F831288C-BC7F-4265-A707-3994194661C5Q59404134-708BA226-FC01-486E-9877-3A99FA7A9418Q59404148-2F376F29-88E3-4201-A9E8-1EC57A20E1E2Q59404155-12885F7C-FC7F-45D5-A704-4A35804B848EQ60962033-F12B53E8-FB9B-4C95-A97D-494822245F52Q61947619-7E2EFF56-F651-4053-9B3E-1676E0ABC11EQ64087283-F94E267C-F946-4F1A-8D22-8952740A446AQ64258674-6D7168BA-E40A-45FD-93C7-3E8A078E8753Q64284501-10032F81-AC72-4F16-BAFC-C0169015DE6CQ90750825-CC64E855-1CB6-4428-A4D6-7AF2F7E6B016Q91298639-C6D822D0-C643-40CB-B7B7-74811195242AQ91593049-3C97C43E-0751-4D39-8F1F-47CE22533788Q95409429-2F25FDC8-1081-4E9C-9A8A-E4C470B0DF38
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Natalia Chueca
@ast
Natalia Chueca
@en
Natalia Chueca
@es
Natalia Chueca
@nl
Natalia Chueca
@sl
type
label
Natalia Chueca
@ast
Natalia Chueca
@en
Natalia Chueca
@es
Natalia Chueca
@nl
Natalia Chueca
@sl
prefLabel
Natalia Chueca
@ast
Natalia Chueca
@en
Natalia Chueca
@es
Natalia Chueca
@nl
Natalia Chueca
@sl
P1053
K-5225-2014
P106
P21
P31
P3829
P496
0000-0002-3420-3290